Literature DB >> 18471509

Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups.

Robert C Kapel1, Jocelyne K Miller, Carlos Torres, Saime Aksoy, Richard Lash, David A Katzka.   

Abstract

BACKGROUND & AIMS: Most reports on eosinophilic esophagitis (EE) are limited to small series from single institutions. This study describes features of EE in a broader population.
METHODS: A national pathology database (Caris Diagnostics, Irving, TX) was used to identify EE cases from a cohort of upper endoscopies. Slides from potential cases were reviewed by pathologists. Study inclusion required a mean of (1) 20 eosinophils or more in 5 high-power fields, or (2) 30 eosinophils in 2-4 high-power fields. Endoscopists provided demographic and clinical information.
RESULTS: There were 363 cases identified from 74,162 patients and 26 states. EE had a male predominance (odds ratio, 3.0; 95% confidence interval, 2.4-3.8). Ages ranged from 1 to 98 years, including 42 children and 321 adults. The most common endoscopy indications in adults were dysphagia (70.1%) and gastroesophageal reflux disease (GERD)/heartburn (27.1%). Children most frequently reported GERD/heartburn (38.1%) and abdominal pain/dyspepsia (31.0%). A total of 25.1% of cases had a peak mucosal eosinophil count of 20-59, 29.2% had a peak mucosal eosinophil count of 60-100, and 45.7% had a peak mucosal eosinophil count of more than 100. There was no difference in the peak counts between age groups or sexes, but patients with dysphagia had higher counts (P < .001). The prevalence of EE increased during the study period (P < .001).
CONCLUSIONS: EE is a national disease found in all age groups, more frequently in males. Dysphagia and GERD symptoms are common indications for endoscopy. The degree of eosinophilic infiltration is high throughout all ages and may be related to patients' symptoms. Our series highlights important elements of this disease, the prevalence and/or recognition of which is increasing.

Entities:  

Mesh:

Year:  2008        PMID: 18471509     DOI: 10.1053/j.gastro.2008.02.016

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  93 in total

1.  Adult patients with eosinophilic esophagitis do not show an increased frequency of the HLA-DQ2/DQ8 genotypes predisposing to celiac disease.

Authors:  Alfredo J Lucendo; Ángel Arias; Isabel Pérez-Martínez; Antonio López-Vázquez; Jesús Ontañón-Rodríguez; Sonia González-Castillo; Livia C De Rezende; Luis Rodrigo
Journal:  Dig Dis Sci       Date:  2010-08-20       Impact factor: 3.199

Review 2.  Diagnosis and management of eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2012-06-19       Impact factor: 11.382

Review 3.  Eosinophilic Esophagitis.

Authors:  Glenn T Furuta; David A Katzka
Journal:  N Engl J Med       Date:  2015-10-22       Impact factor: 91.245

4.  Increased Risk of Esophageal Eosinophilia and Eosinophilic Esophagitis in Patients With Active Celiac Disease on Biopsy.

Authors:  Elizabeth T Jensen; Swathi Eluri; Benjamin Lebwohl; Robert M Genta; Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2015-02-24       Impact factor: 11.382

Review 5.  Management of pediatric eosinophilic esophagitis: an update.

Authors:  Seema Khan
Journal:  Paediatr Drugs       Date:  2012-02-01       Impact factor: 3.022

6.  Development and validation of a registry-based definition of eosinophilic esophagitis in Denmark.

Authors:  Evan S Dellon; Rune Erichsen; Lars Pedersen; Nicholas J Shaheen; John A Baron; Henrik T Sørensen; Mogens Vyberg
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

7.  Administrative coding is specific, but not sensitive, for identifying eosinophilic esophagitis.

Authors:  D A Rybnicek; K E Hathorn; E R Pfaff; W J Bulsiewicz; N J Shaheen; E S Dellon
Journal:  Dis Esophagus       Date:  2013-11-12       Impact factor: 3.429

8.  Epidemiology of eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Gastroenterol Clin North Am       Date:  2014-03-19       Impact factor: 3.806

Review 9.  Eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Gastroenterol Clin North Am       Date:  2012-12-27       Impact factor: 3.806

Review 10.  T cell co-stimulatory molecules: a co-conspirator in the pathogenesis of eosinophilic esophagitis?

Authors:  Zili Zhang; Thomas J Sferra; Yasemen Eroglu
Journal:  Dig Dis Sci       Date:  2013-03-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.